Common Mild Reactions Local irritation where the peptide was injected (minor redness or tenderness) Occasional dizziness or fatigue shortly after use Typically mild and short-lived Potential Risks Not FDA-approved for Lyme disease or any other condition Contraindicated in active cancer due to its angiogenesis-promoting properties Should be avoided during pregnancy or breastfeeding Take Precautions with Medical Guidance Since its administered via injection and isnt regulated for Lyme treatment, a professional Lyme disease expert should guide your dosing
Contact with the round window membrane is maintained for 30 minutes by placing the animal in a recumbent position Intratympanic injectionEach animal is positioned so that the head is tilted at an angle to favor injection towards the round window niche
Sergey Terushkin, MD, FACS (954) 551-3508 1911 Harrison Street, Hollywood, FL 33020 Yes
Our treatments use carefully selected blends of antioxidants, vitamins, and hydrating agents that can help: Support the bodys natural defense against oxidative stress
This study investigates the properties of polymersomes comprised of poly(2-methyl-2-oxazoline)-block-poly(dimethylsiloxane)-block-poly(2-methyl-2-oxazoline) (PMOXA-b-PDMS-b-PMOXA)
Support glutathione levels through precursors like N-acetyl cysteine (NAC), or take glutathione directly